New Roads Open Up for Implementing Immunotherapy in Mesothelioma
Figure 2
Schematic drawing showing the administration of ex vivo cultured mature dendritic cells into a patient (1), resulting in antigen presentation in the lymph node (2) and a specific antitumour cytotoxic antitumour response (3). Tumour cells are depicted as dark cells.